<DOC>
	<DOCNO>NCT02342834</DOCNO>
	<brief_summary>The purpose study : - measure size effect glucose tolerance small mixed protein lipid meal give pre-load individual different glucose tolerance status - investigate underlying mechanism accurately evaluate beta cell function , insulin sensitivity , insulin clearance glucose kinetics ( oral absorption , endogenous production , rate utilization ) together gut hormone plasma concentration .</brief_summary>
	<brief_title>Effects Small Protein Lipid Preload Glucose Tolerance Subjects With Impaired Glucose Homeostasis</brief_title>
	<detailed_description>As support experimental clinical data , oral carbohydrate tolerance influence coingestion nutrient multiple mechanism . The ingestion , contact gastric mucosa , arrival intestine subsequent digestion know produce neural reflex , hormonal response plasma substrates gradient , modulate gastric emptying , insulin secretion insulin clearance participate regulation postprandial glycaemia . The size effect influence number factor : specific nutrient chemical characteristic ( fat v protein composition ) physical property ( solid v liquid ) , time ( pre-load v coingestion ) finally individual glucose tolerance status . To knowledge , effect glucose excursion combination protein fat give carbohydrate still unknown also unknown contribution different mechanism involve control glucose homeostasis subject different degree glucose tolerance .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>healthy , prediabetic dietcontrolled type 2 diabetic patient Subjects ≥ 18 ≤65 year age Lean , Overweight Obese ( BMI : 18 35 kg/m2 ) Normal liver kidney function Normal thyroid function Read understood inform consent form sign voluntarily Liver , heart , kidney , lung , infectious , neurological , psychiatric , immunological neoplastic disease . Type 1 insulin treat diabetes . Pregnancy lactation Illicit drug abuse alcoholism Subject treat insulin treatment Subjects take anoretic drug Subjects steroid treatment Subjects bariatric surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>